glp 1 lawsuit update GLP-1 Medications Chicago attorney Matt Williams discusses

Its a hormonal disorder that can lead to symptoms such as weight gain, acne, hair loss, and infertility

Again, this is an animal study, so it may not hold true for humans

[5] GLP-1 agonist market in the UK and Europe In the UK, the GLP-1 receptor agonist market reached a revenue of $847 million USD in 2024, with an expected revenue of $2.2 billion by 2030 and a CAGR of 16% between 2025 and 2030

Scott Brunner, CEO of the Alliance for Pharmacy Compounding, said the big picture to watch is how people react to losing access to compounded weight-loss drugs

it may be cellular

Still, GLP-1 medications may have benefits far beyond weight loss for heart and liver health, for example which may extend even to people who dont lose as many pounds as they might have expected, experts say